Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
170
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 313 publications
(171 citation statements)
references
References 100 publications
0
170
0
1
Order By: Relevance
“…Nucleotide delivery requires carriers that are safe, are capable of efficient endocytosis into tumor cells, and possibly possess targeting capabilities for delivery to specific cells. [25][26][27][28] In the present study, we chose the polymer PLGA for the preparation of nanoparticles to deliver miR-150 due to advantages of PLGA over other polymers. PLGA-based polymer matrices exhibit tremendous versatility that allows for their tailoring to meet the specific need.…”
Section: Discussionmentioning
confidence: 99%
“…Nucleotide delivery requires carriers that are safe, are capable of efficient endocytosis into tumor cells, and possibly possess targeting capabilities for delivery to specific cells. [25][26][27][28] In the present study, we chose the polymer PLGA for the preparation of nanoparticles to deliver miR-150 due to advantages of PLGA over other polymers. PLGA-based polymer matrices exhibit tremendous versatility that allows for their tailoring to meet the specific need.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, there have been reported successful nonviral siRNAs deliveries with other systems like polymers, 119,120 peptides, 121 dendrimers, 122 lipids, 123 or metallic nanoparticles 124 among many other systems. 125,126 In fact, the use of hybrid carriers containing polycationic fragments also enables the combination of features from both components. Among all reported nanodevices, there could be highlighted those which facilitate endosomal escape, 127,128 or are able to perform a dual therapeutic action.…”
Section: Surface Deposition Of Nucleic Acids Onto Msns For Gene Transmentioning
confidence: 99%
“…Although this seems easy, the complexity of siRNA transfection is challenging once these biomolecules are too large and too hydrophilic to cross the cell membrane without the help of a transfection agent. Nanotechnology offers versatile targeted delivery platforms for RNAi therapeutics [36,37]. In the last 15 years the use of inorganic nanoparticles (gold, magnetic, silica and quantum dots) as siRNAs delivery agents has been investigated and extensively described.…”
Section: Inorganic Nanoparticles As Sirna Carriersmentioning
confidence: 99%